Literature DB >> 6267560

Localization and opiate receptor binding of enkephalin, CCK and ACTH/beta-endorphin in the rat central nervous system.

K Stengaard-Pedersen, L I Larsson.   

Abstract

We have examined the distributions of ACTH, CCK and enkephalin immunoreactive nerves in the rat central nervous system and compared the pattern obtained with that of opiate receptors. In addition, a radioreceptor assay has been employed for studying the possible functional interactions between these peptides and opiate receptors. Our results suggest that: (a) The distribution of enkephalin, CCK and ACTH/beta-endorphin immunoreactive nerve terminals is sufficiently similar to suggest functional interaction between these neuropeptides. (b) The CCK immunoreactive nerves display a distribution similar to that of enkephalin, but the main endogenous CCK forms do not bind to opiate receptors. However, opioid peptides and CCK may interact in many brain regions via binding to different, but functionally interacting receptors. (c) The ACTH immunoreactive nerves, which seem also to contain beta-endorphin, shows a partially overlapping distribution with the enkephalinergic systems. Further, ACTH and its fragments bind to opiate receptors. This suggests that ACTH could be an endogenous opioid ligand.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267560     DOI: 10.1016/0196-9781(81)90050-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.

Authors:  Richard S Agnes; Yeon Sun Lee; Peg Davis; Shou-Wu Ma; Hamid Badghisi; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  J Med Chem       Date:  2006-05-18       Impact factor: 7.446

2.  Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.

Authors:  Jennifer Y Xie; David S Herman; Carl-Olav Stiller; Luis R Gardell; Michael H Ossipov; Josephine Lai; Frank Porreca; Todd W Vanderah
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

3.  Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.

Authors:  L Singh; R J Oles; M J Field; P Atwal; G N Woodruff; J C Hunter
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

4.  Induced association of mu opioid (MOP) and type 2 cholecystokinin (CCK2) receptors by novel bivalent ligands.

Authors:  Yaguo Zheng; Eyup Akgün; Kaleeckal G Harikumar; Jessika Hopson; Michael D Powers; Mary M Lunzer; Laurence J Miller; Philip S Portoghese
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

5.  Modulation of cholecystokinin concentrations in the rat hippocampus by chelation of heavy metals.

Authors:  K Stengaard-Pedersen; L I Larsson; K Fredens; J F Rehfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.